Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies [Phase 2]
A Phase 2 trial evaluating a combination of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with previously treated lymph…
-
CLINICAL_TRIALS research · 2017-06-27Clinical Trial Update: DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701
This clinical trial update reports findings from DNA analysis aimed at predicting which follicular lymphoma patients respond to antibody the…
-
FDA approval · 2017-06-22FDA Approved: RITUXAN HYCELA — Original Application (Genentech, Inc.)
FDA approved RITUXAN HYCELA (rituximab and hyaluronidase) under an Original Application by Genentech. The subcutaneous formulation provides …
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial of combining veltuzumab with fractionated Y-90 epratuzumab radioimmunotherapy in follicular lymphoma; study terminated with …
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Evaluate Rituximab in Obtaining PCR (Polymerase Chain Reaction) Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma [Phase 2]
This Phase 2 clinical trial update evaluates whether rituximab can help achieve PCR-negative leukapheresis products in patients with relapse…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating a multi-modality approach combining Yttrium-90 ibritumomab tiuxetan, fludarabine, radiation therapy, and d…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Open-label Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Auriхim [Phase 1]
Open-label Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of Aurixim in lymphoma patients; study compl…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma [Phase 2]
Phase 2 study evaluating rituximab plus dexamethasone in patients with low-grade non-Hodgkin lymphoma, including follicular and marginal zon…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…
-
CLINICAL_TRIALS withdrawal · 2017-05-19Clinical Trial Update: Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma [Phase 2]
The Phase 2 trial of Brentuximab Vedotin, Bendamustine, and Rituximab for relapsed or refractory B-cell non-Hodgkin lymphoma has been withdr…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating idelalisib plus rituximab for previously untreated follicular lymphoma and small lymphocytic lymphoma was terminate…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402
An update on the completed ECOG-E4402 study reports on DNA analyses to identify biomarkers that influence response to rituximab in patients …
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma
This clinical trial update reports on biomarkers that may predict response to rituximab in samples from patients with indolent follicular ly…
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab
This completed clinical trial update discusses biomarker analyses in samples from patients with Follicular lymphoma treated with Rituximab.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Safety and Tolerability of HSC835 in Patients With Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and tolerability of HSC835 in patients with various hematologic malignancies completed with results posted …
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating bortezomib plus vorinostat as maintenance after autologous stem cell transplant in non-Hodgkin lymphoma showed resu…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial of oral clofarabine in relapsed/refractory non-Hodgkin lymphoma completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Clinical trial update reporting Phase 2 results for rituximab in combination with denileukin diftitox in previously untreated stage III or I…
-
CLINICAL_TRIALS research · 2017-03-23Clinical Trial Update: An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma
This clinical trial update describes an observational study assessing treatments, outcomes, and prognosis for patients with follicular lymph…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon
A follow-up clinical trial involving Rituximab and alpha interferon for follicular lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma [Phase 2]
A Phase 2 study evaluating ofatumumab as initial systemic therapy for indolent B-cell lymphomas has completed, with results posted in March …
-
CLINICAL_TRIALS research · 2017-03-16Clinical Trial Update: Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma [Phase 1, Phase 2]
This document describes a Phase 1/2 clinical trial evaluating competitive transfer of two αCD19-TCRz-CAR-T cell constructs (one with CD28 an…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas [Phase 2]
Phase 2 trial update evaluating intratumoral PF-3512676 plus local radiation in low-grade Non-Hodgkin lymphoma, including follicular/indolen…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Primary Rituximab and Maintenance [Phase 3]
A Phase 3 trial evaluating primary rituximab therapy with maintenance for follicular lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Anti-CD22 CAR-T Therapy for CD19-refractory or Resistant Lymphoma Patients [Phase 1]
Phase 1 clinical trial update of an anti-CD22 CAR-T therapy for CD19-refractory or resistant lymphomas, including diffuse large B-cell lymph…